Articles Archives - Page 7 of 624

MondayApr 01, 2024 9:45 am

Turbo Energy S.A. (NASDAQ: TURB) Powering the Future: Tech-Infused Photovoltaics and the Path to Sustainable Energy

The global solar energy market is forecasted by Fortune Business Insights to rise from $3.33 billion in 2022 to over $20 billion by 2030 Turbo Energy S.A. will be part of the explosive growth, as tech-infused photovoltaics become instrumental in more efficient use of solar energy Turbo Energy S.A. is a leader in the residential markets in Spain, offering a complete lineup of Li-ion batteries, inverters, software, and their turnkey product, Sunbox The world is facing a critical juncture. Our dependence on fossil fuels has demonstrably contributed to climate change, necessitating a global shift towards cleaner, more sustainable energy sources.…

MondayApr 01, 2024 9:00 am

Sigyn Therapeutics Inc. (SIGY) CEO Discusses Company’s Blood Purification Therapies to Address Cancer and Other Life-Threatening Conditions at the Emerging Growth Conference

Sigyn Therapeutics CEO Jim Joyce reviewed the company’s pipeline of technologies, including ChemoPrep(TM), ChemoPure(TM), and ImmunePrep(TM) to improve patient responses to various cancer therapies, and Sigyn Therapy(TM) to address drug resistant viral and bacterial infections, endotoxemia, and sepsis, a leading cause of hospital deaths in the United States The company created Sigyn Therapy(TM) to treat pathogen-associated disorders that are not addressed with drug therapies Sigyn Therapeutics is developing ChemoPrep(TM) and ImmunePrep(TM), to improve patient responses to chemotherapy and immunotherapeutic antibodies, respectively To reduce toxicity, the company designed ChemoPure(TM) to sweep off-target chemotherapy from the bloodstream before it is able to cause…

ThursdayMar 28, 2024 9:45 am

Longeveron Inc. (NASDAQ: LGVN) Discusses 2023 Progress and 2024 Plans in Corporate Update

Longeveron recently released its full-year results for the period ended December 31, 2023, and provided a corporate update The update outlined the company’s plans to prioritize the development of Lomecel-B(TM) in Hypoplastic Left Heart Syndrome (“HLHS”), a rare, pediatric congenital heart condition characterized by an underdeveloped left side of the heart Longeveron plans to complete the enrollment in the ELPIS II trial for HLHS in 2024 The company also reported that it is exploring opportunities to advance its Alzheimer’s disease program through potential partnerships or other sources of funding Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicine for…

ThursdayMar 28, 2024 9:00 am

Astrotech Corp. (NASDAQ: ASTC) and AgLAB Inc. Use Mass Spectrometer Technology to Significantly Enhance Hemp and Cannabis Production Yield and Profit

The cannabinoid market value in 2023 was $22.23 billion and is expected to grow at a CAGR of 15.3%, resulting in an estimated market value of $60.36 billion The global mass spectrometry market will reach $6.77 billion in 2024 and is expected to grow at a CAGR of 6.25%, reaching $9.17 billion by 2029. Astrotech and subsidiary AgLAB Inc. are using mass spectrometry to boost the profitable yield of hemp and cannabis production The United States has seen a rising awareness of the health and therapeutic benefits of cannabinoids, prompting an expected market increase of 15.3%, from $22.23 billion in…

WednesdayMar 27, 2024 10:26 am

Turbo Energy (NASDAQ: TURB) Advances Patented, AI-Powered Energy Storage Solution as EU Market Surges

Demand for photovoltaic energy storage systems in the EU is growing, driven by increased demand for energy security, renewable energy sources, and grid stability TURB strongly positioned with patented Sunbox - an AI-powered solution for home and business photovoltaic systems Sunbox leverages AI-powered algorithms to optimize energy usage, maximize efficiency, and protect against price shocks Market size for solar energy storage batteries projected to grow from $4.40 billion in 2023 to $20.01 billion by 2030 at a CAGR of 24.2% Demand for photovoltaic energy storage systems in the European Union is growing, driven by environmental concerns and the goal of…

WednesdayMar 27, 2024 9:45 am

Bravo Multinational Inc. (BRVO) Capturing Entertainment Industry Growth Opportunities Through Multiple Ventures

Video streaming is expected to reach a market size of $279.5 million in 2024 and grow to $1.3 billion by 2034 due to the demand for live-streamed content and technology advancements Immersive content is in high demand – blending lifestyle content with entertainment elements, often through apps supporting Video-On-Demand content and traditional broadcast television Bravo's acquisition of Streaming TVee's assets further the company's goal of advancing its video streaming and entertainment ventures with a beta launch of its TVee NOW(TM) streaming service in Q1 2024 The video streaming market is expected to keep growing in the coming years. It is…

TuesdayMar 26, 2024 10:30 am

SUIC Worldwide Holdings Ltd. (SUIC) Is ‘One to Watch’

In February 2024, SUIC’s I.Hart Group signed an agreement with Taiwan’s largest convenience store chain, 7-Eleven Group, to distribute I.Hart’s Monga fried chicken That same month, SUIC and I.Hart announced the grand opening of their fourth Monga fried chicken store in Hong Kong. In tandem with the Hong Kong opening, SUIC and I.Hart announced the rollout of six Monga outlets in Fujian, China, and plans to open hundreds of Monga outlets in the U.S. The company’s fintech group has nine revolutionary patents with several ALL-IN-ONE products; its fintech section is fast-growing with increasing market share, and its fintech R&D group…

TuesdayMar 26, 2024 9:45 am

Astiva Health’s Innovative Strategies for Enhancing Senior Mobility and Independence

Astiva Health Inc. is pioneering transformative healthcare for seniors, with a focus on enhancing mobility and promoting independence. This innovative approach places a strong emphasis on seniors as active participants in their healthcare journey, representing a shift towards a more interactive and preventive model of care. Embracing Active Participation Central to Astiva Health's mission is empowering seniors to engage actively in their healthcare decisions, supporting their flourishing in later years. The CDC highlights physical activity's crucial role in preventing chronic diseases among seniors, noting that regular physical activity can significantly reduce health risks associated with inactivity (CDC, 2020). Tailored Exercise…

TuesdayMar 26, 2024 9:00 am

Clene Inc. (NASDAQ: CLNN) Announces Operational Highlights for Lead Therapeutic Candidate for ALS and MS

Clene’s recently released 2023 financial and operational updates highlight the company’s developments for the treatment of amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis CNM-Au8(R) functions as a neuroprotective and remyelinating therapy in neurodegenerative diseases Recent data from the randomized, double-blind, placebo-controlled HEALEY-ALS Platform Trial and its open-label extension, reported by Clene in December 2023, revealed encouraging outcomes on survival and delayed clinical worsening Clene recently provided perspectives on its achievements and the development path for CNM-Au8(R) during its participation in the 36th Annual ROTH Conference, which was held March 18-19, 2024 Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene…

MondayMar 25, 2024 12:45 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires Contract Research Organization to Perform Important GLP-1 Human Pilot Study

Lexaria, a global innovator in drug delivery platforms, recently hired a Contract Research Organization to perform their second GLP-1 human pilot study which will test a dissolvable DehydraTECH-GLP-1 oral dose formulation The announcement follows Lexaria’s WEIGHT-A24-1 animal study announcement examining diabetes and weight loss effects of DehydraTECH-processed GLP-1 drugs and cannabidiol alone and in combination The move aligns with the company’s resolve to focus on their ability to enhance the delivery of GLP-1 diabetes and obesity drugs At the beginning of the year, Lexaria Bioscience (NASDAQ: LEXX), a global innovator for enhanced drug delivery platforms, announced its intention to double…

Site Search

Company Search

Category: Articles